Biosimilars Council calls for better regulatory pathways for critical medicines
The Biosimilars Council, a division of the Association for Accessible Medicines, the leading trade association for generic and biosimilar manufacturers, published a new position paper outlining the benefits of updating the existing Food and Drug Administration regulatory process for biosimilar medic